ConductScience.org, home

Paper7600564

Potentiation of antitumor effects of tumor necrosis factor alpha and interferon gamma by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice.

Lasek W and 7 others. Cancer Immunol Immunother, 1995. Cited by 39 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Potentiation of antitumor effects of tumor necrosis factor alpha and interferon gamma by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice. Papers, record 7600564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7600564

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Potentiation of antitumor effects of tumor necrosis factor alpha and interferon gamma by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
0.98
iCite
Revised in PubMed
2024-04-26
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lasek WW
2Wańkowicz AA
3Kuc KK
4Feleszko WW
5Gołab JJ
6Giermasz AA
7Wiktor-Jedrzejczak WW
8Jakóbisiak MM

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunologic FactorsMajor topic
Interferon-gammaMajor topic
Macrophage Colony-Stimulating FactorMajor topic
Melanoma, ExperimentalMajor topic
Tumor Necrosis Factor-alphaMajor topic
Animals
Bone Marrow
Disease Progression
Drug Screening Assays, Antitumor
Drug Synergism
Male
Mice
Mice, Inbred C57BL
Mice, Inbred DBA
Monocytes
Recombinant Proteins

Source PubMed

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13,497,112Combination tumor-immunotherapy with recombinant tumor necrosis factor and recombinant interleukin 2 in mice.Int J Cancer1987https://conductscience.org/library/papers/3497112PubMed
23,095,251In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma.Int J Cancer1986https://conductscience.org/library/papers/3095251PubMed
33,121,728Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.J Immunol1987https://conductscience.org/library/papers/3121728PubMed
48,394,092Macrophage activation by T cells: cognate and non-cognate signals.Curr Opin Immunol1993https://conductscience.org/library/papers/8394092PubMed
58,033,141Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.Cancer Res1994https://conductscience.org/library/papers/8033141PubMed
63,089,802Recombinant tumor necrosis factor: its effect and its synergism with interferon-gamma on a variety of normal and transformed human cell lines.Eur J Cancer Clin Oncol1986https://conductscience.org/library/papers/3089802PubMed
72,021,943Biological and antitumor effects of recombinant human macrophage colony-stimulating factor in mice.Cancer Res1991https://conductscience.org/library/papers/2021943PubMed
83,053,899The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo.J Immunol1988https://conductscience.org/library/papers/3053899PubMed
98,196,902Macrophage colony-stimulating factor for cancer therapy.Oncology1994https://conductscience.org/library/papers/8196902PubMed
108,276,722Leukemic cell lysis by activated human macrophages: significance of membrane-associated tumor necrosis factor.Jpn J Cancer Res1993https://conductscience.org/library/papers/8276722PubMed
118,196,898Tumor necrosis factor for the treatment of malignancies.Oncology1994https://conductscience.org/library/papers/8196898PubMed
128,505,145Effect of interferon-gamma, tumor necrosis factor, interleukin-1 and interleukin-6 on the modulation of anti-tumor responses of bone marrow derived macrophages.Int J Immunopharmacol1993https://conductscience.org/library/papers/8505145PubMed
138,293,417Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan.Cancer1994https://conductscience.org/library/papers/8293417PubMed
141,985,870Anti-tumor effects of recombinant human macrophage colony-stimulating factor, alone or in combination with local irradiation, in mice inoculated with Lewis lung carcinoma cells.Int J Cancer1991https://conductscience.org/library/papers/1985870PubMed
158,345,197Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 alpha, tumor necrosis factor-alpha, and IFN-gamma.J Immunol1993https://conductscience.org/library/papers/8345197PubMed
162,428,865Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity.J Immunol1986https://conductscience.org/library/papers/2428865PubMed
173,053,901Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.J Immunol1988https://conductscience.org/library/papers/3053901PubMed
183,131,832Therapeutic potential of cytokines: a comparison of preclinical and clinical studies.Prog Exp Tumor Res1988https://conductscience.org/library/papers/3131832PubMed
196,982,897Structure-function studies of a colony stimulating factor (CSF-1).J Biol Chem1982https://conductscience.org/library/papers/6982897PubMed
208,419,170Macrophage colony-stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppression.Eur J Immunol1993https://conductscience.org/library/papers/8419170PubMed

See all 34 references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
31,293,965The Melding of Drug Screening Platforms for Melanoma.Front Oncol2019https://conductscience.org/library/papers/31293965PubMed
19,399,188A novel triterpenoid isolated from the root bark of Ailanthus excelsa Roxb (Tree of Heaven), AECHL-1 as a potential anti-cancer agent.PLoS One2009https://conductscience.org/library/papers/19399188PubMed
18,947,424The prince and the pauper. A tale of anticancer targeted agents.Mol Cancer2008https://conductscience.org/library/papers/18947424PubMed
18,472,817Cancer immunotherapy: potential involvement of mediators.Mediators Inflamm1997https://conductscience.org/library/papers/18472817PubMed
16,709,225Tumour-associated macrophages and melanoma tumourigenesis: integrating the complexity.Int J Exp Pathol2006https://conductscience.org/library/papers/16709225PubMed
10,982,366Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases.J Virol2000https://conductscience.org/library/papers/10982366PubMed
8,957,067In vivo anti-tumor efficacy of polyethylene glycol-modified tumor necrosis factor-alpha against tumor necrosis factor-resistant tumors.Jpn J Cancer Res1996https://conductscience.org/library/papers/8957067PubMed

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CSF11,435PubTator's text mininghttps://conductscience.org/library/genes/1435NCBI Gene
TNF7,124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7600564

GET https://conductscience.org/api/papers/v1/7600564/references?page=2